Cited by 184Probiotics and Fermented FoodsMycotoxins in Agriculture and FoodGut microbiota and health

Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China

Open access
El-Nezami, Hani S, Polychronaki, Nektaria N, Ma, Jing, Zhu, Huilian, Ling, Wenhua, Salminen, Eeva K, Juvonen, Risto O, Salminen, Seppo J +2 more·2006·The American Journal of Clinical Nutrition

Abstract

Background In vitro and in vivo studies suggest that selected strains of probiotic bacteria can form tight complexes with aflatoxin B(1) and other carcinogens.Objective The aim of the present study was to determine whether administration of probiotic bacteria could block the intestinal absorption of aflatoxin B(1) and thereby lead to reduced urinary excretion of aflatoxin B(1)-N(7)-guanine (AFB-N(7)-guanine), a marker for a biologically effective dose of aflatoxin exposure. Elevated urinary excretion of this aflatoxin-DNA adduct is associated with an increased risk of liver cancer.Design Ninety healthy young men from Guangzhou, China, were randomly assigned to 2 groups; one group received a mixture of Lactobacillus rhamnosus LC705 and Propionibacterium freudenreichii subsp. shermanii strains 2 times/d for 5 wk, and the other group received a placebo preparation. The subjects provided 4 urine samples: at baseline, at 3 and 5 wk after starting the supplementation, and at the end of the 5-wk postintervention period.Results The percentage of samples with negative AFB-N(7)-guanine values tended to be higher in the probiotic group than in the placebo group during the 5-wk intervention period (odds ratio: 2.63, P = 0.052), and a statistically significant decrease in the concentration of urinary AFB-N(7)-guanine was observed in the probiotic group. The reduction was 36% at week 3 and 55% at week 5. The geometric means for the probiotic and placebo groups were 0.24 and 0.49 ng AFB-N(7)-guanine/mL, respectively, during the intervention period (P = 0.005).Conclusion A probiotic supplement reduces the biologically effective dose of aflatoxin exposure and may thereby offer an effective dietary approach to decrease the risk of liver cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ajcn/83.5.1199

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Mykka ¨nen H, Zhu H, Salminen E, et al. Fecal and urinary excretion of aflatoxin B1 metabolites (AFQ1, AFM1, AFB-N7-guanine) in young Chinese males. Int J Cancer 2005;115:879 -84.

Cited by

Sorted by citations

Authors
El-Nezami, H. S., Polychronaki, N. N., Ma, J., Zhu, H., Ling, W., Salminen, E. K., Juvonen, R. O., Salminen, S. J., Poussa, T., & Mykkänen, H. M.
Affiliations
University of Turku (FI)
Corresponding author
El-Nezami, Hani S
Venue
The American Journal of Clinical Nutrition
Publisher
Elsevier BV
Published
2006-05
Volume
83
Issue
5
Pages
1199-1203
ISSN
0002-9165 (ISSN-L)
OpenAlex
W2164252115
Cited by
184
References
33
Citations by year
2026: 7 · 2025: 11 · 2024: 9 · 2023: 14 · 2022: 7 · 2021: 5 · 2020: 15 · 2019: 11 · 2018: 13 · 2017: 10 · 2016: 8 · 2015: 16 · 2014: 7 · 2013: 6 · 2012: 9
FWCI
10.20
Type
journal article
Language
en
Open access
Locations
  • American Journal of Clinical Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Mycotoxins in Agriculture and Food
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
probiotics, aflatoxin B1, liver cancer risk, Propionibacterium freudenreichii subsp. shermanii, dietary cancer prevention, young men
MeSH terms
China, Double-Blind Method, Guanine, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Placebos, Propionibacterium, Risk Factors, Biomarkers, Tumor, Aflatoxin B1, DNA Adducts, Probiotics, Lacticaseibacillus rhamnosus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review